CSPC Pharmaceutical Group Limited (CVG) — Cash Flow-to-Debt Ratio
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow-to-Debt Ratio of 0.25x as of June 2020, meaning its operating cash flow of €2.16 Billion could theoretically repay 0% of its total liabilities (€8.46 Billion) in one year. Explore CSPC Pharmaceutical Group Limited (CVG) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CSPC Pharmaceutical Group Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for CSPC Pharmaceutical Group Limited across 13 annual periods. Also explore CVG current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year debt coverage analysis for CSPC Pharmaceutical Group Limited. For market capitalisation and broader financial context, see CSPC Pharmaceutical Group Limited (CVG) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | €5.83 Billion | €12.15 Billion | ▲ +11.4% |
| 2024 | 0.43x | €4.53 Billion | €10.52 Billion | ▲ +16.2% |
| 2023 | 0.37x | €4.18 Billion | €11.26 Billion | ▼ -50.7% |
| 2022 | 0.75x | €7.63 Billion | €10.13 Billion | ▲ +28.5% |
| 2021 | 0.59x | €4.64 Billion | €7.91 Billion | ▼ -39.4% |
| 2020 | 0.97x | €6.74 Billion | €6.97 Billion | ▲ +73.8% |
| 2019 | 0.56x | €3.78 Billion | €6.80 Billion | ▲ +12.5% |
| 2018 | 0.49x | €3.80 Billion | €7.67 Billion | ▼ -22.9% |
| 2017 | 0.64x | €3.29 Billion | €5.13 Billion | ▼ -10.0% |
| 2016 | 0.71x | €2.92 Billion | €4.09 Billion | ▲ +49.8% |
| 2015 | 0.48x | €2.25 Billion | €4.73 Billion | ▲ +14.6% |
| 2014 | 0.42x | €1.81 Billion | €4.35 Billion | ▲ +134.6% |
| 2013 | 0.18x | €814.86 Million | €4.60 Billion | — |